O.K. But the Ohio pharmacy board, in a coordinated effort (telephone conference call and followup public letter) with other state pharmacy boards, should be seeking for the drug manufactures to increase their production of hydroxychloroquine. Why? Because it is a supply issue and it is not as if the supply going to the pharmacies could not be increased. They experience the supply problem but restricting its use by the pharmacy is only one half of the solution. The other is increased production. They can publicly make that case with more affect than can the individual patients and doctors seeking to use the drug.
Wuli wrote:
“O.K. But the Ohio pharmacy board, in a coordinated effort (telephone conference call and followup public letter) with other state pharmacy boards, should be seeking for the drug manufactures to increase their production of hydroxychloroquine. Why? Because it is a supply issue and it is not as if the supply going to the pharmacies could not be increased. They experience the supply problem but restricting its use by the pharmacy is only one half of the solution. The other is increased production. They can publicly make that case with more affect than can the individual patients and doctors seeking to use the drug.”
Israel is sending hydroxychloroquine to the US.
Bayer is sending meds also.
The drug is generic. In addition to Bayer donating millions of doses, Mylan, Teva and Novartis are all actively manufacturing. There is no shortage, FDA needs to get off their asses and approve it for use. That is what Trump hit the, with last week. Just get it done.